- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04598503
Congenital Anomalies and Risk Factors
October 16, 2020 updated by: Amira Shalaby, Assiut University
Prevalence, Types and Risk Factors of Congenital Anomalies(A Hospital Based Study)
The aim of the study is to determine the prevalence, describe the types and risk factors of congenital anomalies among newborns admitted to Neonatal Intensive Care Unit (NICU) of Assiut University Children Hospital (AUCH).
It is a prospective and a case control study was performed and screening of the newborn admitted at NICU of Assiut University Children Hospital during the period of 6 months from 1-12-2017 to the end of 5-2018 the sample was 346 newborns, 173 cases and 173 control.
Data were collected using a record checklist and an interviewing questionnaire.
Conclusion: The prevalence of congenital anomalies was 22.97%.
The most common anomalies were gastrointestinal anomalies (GIT), musculoskeletal anomalies, multiple anomalies and circulatory system anomalies.
The risk factors were consanguineous marriage, positive family history, urban areas, full-term and singleton pregnancies.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of the study is to determine the prevalence, describe the types and risk factors of congenital anomalies among newborns admitted to Neonatal Intensive Care Unit (NICU).
Study design: This is a prospective case control study was carried out in the neonatal intensive care unit.
It is a tertiary care center.
The center provides multi-specialist care and serves as a major referral center for hospitals within and outside the city.
The study was done during the period of 6 months from December 2017 to May 2018.
Patients: All the babies admitted to the hospital with congenital anomalies during this period were included.
All stillbirths were excluded from this study.
The sample was 346 newborns, 173 cases and 173 control.
For each case, a detailed perinatal and maternal and family history were obtained by interviewing questionnaire.
Diagnosis of congenital anomalies was based on clinical evaluation of newborn babies by the neonatologist and other appropriate investigations such as radiography, ultrasonography, echocardiography and chromosomal analysis etc... Classification of anomalies is done by systems according to WHO international classification of diseases (ICD10) [10].
Data was entered into excel data sheet and appropriate statistical analysis was performed.
The prevalence was calculated by dividing the number of CA during the 6 months (173) by the total number of admission during this period (753).
Statistical analysis: Data were analyzed using (SPSS Statistics for Windows, Version 21.0, NY).
Descriptive analysis of the whole sample; where data were expressed as mean values and standard deviations for quantitative variables, and numbers and frequencies for qualitative variables.
Bivariate analysis was performed to assess associations between various independent variables and the dependent variable (presence of congenital anomalies), chi-square was used to compare the difference in distribution of frequencies among different groups and if number inside the cell was small we used Fisher's Exact Test.
Independent sample T-test was used to compare the difference in means among different groups.
A significant p value was considered when it less than or equal 0.05.
Study Type
Observational
Enrollment (Actual)
346
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Assiut, Egypt, 71511
- Assiut University Children Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 4 weeks (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All the babies admitted to the hospital with congenital anomalies during this period were included.
Description
Inclusion Criteria:
- All the babies admitted to the hospital with congenital anomalies during this period were included.
Exclusion Criteria:
- All stillbirths were excluded from this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
cases
All the babies admitted to the hospital with congenital anomalies during this period were included
|
For each case, a detailed perinatal and maternal and family history were obtained by interviewing questionnaire.
Diagnosis of congenital anomalies was based on clinical evaluation of newborn babies by the neonatologist and other appropriate investigations such as radiography, ultrasonography, echocardiography and chromosomal analysis etc... Classification of anomalies is done by systems according to WHO international classification of diseases (ICD10) [10].
Data was entered into excel data sheet and appropriate statistical analysis was performed.
The prevalence was calculated by dividing the number of CA during the 6 months (173) by the total number of admission during this period (753).
|
|
control
newborns without congenital anomalies
|
For each case, a detailed perinatal and maternal and family history were obtained by interviewing questionnaire.
Diagnosis of congenital anomalies was based on clinical evaluation of newborn babies by the neonatologist and other appropriate investigations such as radiography, ultrasonography, echocardiography and chromosomal analysis etc... Classification of anomalies is done by systems according to WHO international classification of diseases (ICD10) [10].
Data was entered into excel data sheet and appropriate statistical analysis was performed.
The prevalence was calculated by dividing the number of CA during the 6 months (173) by the total number of admission during this period (753).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
prevalence of congenital anomalies
Time Frame: 6months
|
The prevalence was calculated by dividing the number of CA during the 6 months (173) by the total number of admission during this period (753) newborns admitted to Neonatal Intensive Care Unit (NICU)
|
6months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
risk factors
Time Frame: 6months
|
To determined the risk factors of congenital anomalies by a detailed perinatal, maternal and family history were obtained by interviewing questionnaire.
|
6months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Amira M. Shalaby, Lecturer, Assiut University Children Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2017
Primary Completion (Actual)
May 31, 2018
Study Completion (Actual)
May 31, 2018
Study Registration Dates
First Submitted
October 11, 2020
First Submitted That Met QC Criteria
October 16, 2020
First Posted (Actual)
October 22, 2020
Study Record Updates
Last Update Posted (Actual)
October 22, 2020
Last Update Submitted That Met QC Criteria
October 16, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Assiut University CH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Prevalence, types and risk factors of congenital anomalies
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Anomalies
-
Assiut UniversityNot yet recruitingKidney Congenital Anomalies
-
University of California, San FranciscoCompletedSkeletal Anomalies | Multiple Anomalies | Structural Anomalies | Cardiac Anomalies | Central Nervous System Anomalies | Thorax Anomalies | Genito-urinary Anomalies | Gastrointestinal AnomaliesUnited States
-
Konya City HospitalCompletedMultiple AbnormaliesTurkey
-
Aljazeera HospitalKasr El Aini Hospital; National Research Centre, EgyptUnknown
-
Fondazione Policlinico Universitario Agostino Gemelli...Azienda Ospedaliero-Universitaria di Parma; Ospedale Di Venere - Carbonara...RecruitingBrain Malformation | Fetal AnomaliesItaly
-
Assiut UniversityRecruitingMullerian Duct AnomaliesEgypt
-
University of California, San FranciscoEnrolling by invitationFetal Structural AnomaliesUnited States
-
Tanta UniversityActive, not recruitingUrinary Tract Anomalies | Kidney; AnomalyEgypt
-
Children's Hospital of PhiladelphiaWashington University School of Medicine; Novartis; Columbia University; Children... and other collaboratorsActive, not recruitingVascular Anomalies | Vascular Anomaly | Ras/MAPK Pathway Vascular AnomaliesUnited States
-
Rigshospitalet, DenmarkAarhus University Hospital; Bispebjerg Hospital; ActelionCompletedTricuspid Atresia | Hypoplastic Left Heart Syndrome | Other Specified Congenital Anomalies of HeartDenmark, Sweden
Clinical Trials on full history and clinical examination
-
Assiut UniversityNot yet recruitingCT Scan | EUS Guided Biopsy | Pancreatic Lesions Located at the Body or the Tail
-
University Hospital, GhentCompletedKnee Arthrodesis With Intramedullary NailBelgium
-
University Hospital, BonnForschungszentrum Juelich; The Marigold Foundation; Life and Brain Center BonnCompletedMyotonic Dystrophy 1 | Myotonic Dystrophy 2
-
Asian Institute of Gastroenterology, IndiaAll India Institute of Medical Sciences, New Delhi; Aalborg University Hospital and other collaboratorsRecruiting
-
Assiut UniversityNot yet recruitingCongenital Heart Disease
-
University of EdinburghNHS Lothian; Department of Health, United KingdomCompleted
-
Faculty Hospital Kralovske VinohradyActive, not recruiting
-
Diabetes Foundation, IndiaJohns Hopkins University; National Diabetes Obesity and Cholesterol FoundationRecruiting
-
Second Affiliated Hospital, School of Medicine,...The First Affiliated Hospital of Zhejiang Chinese Medical University; Zhejiang...Recruiting